在宅輸液療法の市場規模、シェア、成長分析、製品別、用途別、投与法別、地域別- 産業別予測、2024～2031年

在宅輸液療法の世界市場規模は、2022年に354億米ドルと評価され、2023年の385億米ドルから2031年には718億米ドルに成長し、予測期間中（2024～2031年）のCAGRは8.1％で成長する展望です。

市場洞察によると、患者のコスト削減と在宅治療の需要急増を背景に、特に輸液療法において在宅医療へのシフトが顕著になっています。パンデミックにより病院が資源不足に陥る中、多くの患者が必要不可欠な医療サービスを継続するために在宅医療を選択しました。主要市場促進要因としては、輸液装置の技術的進歩や、患者がより便利な選択肢を求めるにつれて在宅治療への嗜好が高まっていることなどが挙げられます。Option Care Health Inc.のような在宅輸液サービスプロバイダーは、病院や薬局と提携し、患者の治療へのアクセスを合理化し、個人に合わせた治療計画を立てています。このような連携は、特に新興国市場において在宅輸液用品とサービスの需要に拍車をかけ、在宅医療ソリューションの全体的な展望を高めています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場展望
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主要市場の考察

• 重要成功要因
• 競合の程度
• 主要投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩
• 規制情勢
• ケーススタディ
• 特許分析

在宅輸液療法市場規模：製品別&CAGR（2024～2031年）

• 市場概要
• 輸液ポンプ
  • エラストマー
  • 電気機械
  • 重力
  • その他
• 点滴セット
• IVカニューレ
• ニードルレスコネクタ

在宅輸液療法市場規模：用途別&CAGR（2024～2031年）

• 市場概要
• 抗感染
• 内分泌学
  • 糖尿病
  • その他
• 水分補給療法
  • アスリート
  • その他
• 化学療法
• 経腸栄養
• 親の栄養
• 専門医薬品
• その他

在宅輸液療法市場規模：投与経路別&CAGR（2024～2031年）

• 市場概要
• 筋肉内
• 皮下注射
• 硬膜外麻酔

在宅輸液療法市場規模&CAGR（2024～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他のラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主要市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
• 製品ポートフォリオ分析
• セグメント別シェア分析
• 収益の前年比比較（2021～2023年）

主要企業プロファイル

• Baxter International Inc.（米国）
• Fresenius Kabi AG（ドイツ）
• Teva Pharmaceutical Industries Ltd.（イスラエル）
• McKesson Corporation（米国）
• Option Care Health（米国）
• AmerisourceBergen Corporation（米国）
• CVS Health（米国）
• Walgreens Boots Alliance（USA/UK）
• Cardinal Health（米国）
• Linde plc（英国）
• Centene Corporation（米国）
• UnitedHealth Group（米国）
• Anthem, Inc.（米国）
• Humana Inc.（米国）
• Cigna Corporation（米国）
• Koninklijke Philips N.V.（オランダ）
• Smiths Medical（英国）
• ICU Medical, Inc.（米国）
• Terumo Corporation（日本）
• BD（米国）
• 結論&推奨

Global Home Infusion Therapy Market size was valued at USD 35.4 billion in 2022 and is poised to grow from USD 38.5 billion in 2023 to USD 71.8 billion by 2031, growing at a CAGR of 8.1% during the forecast period (2024-2031).

Market insights indicate a significant shift towards home healthcare, particularly in infusion therapies, driven by reduced patient costs and a surge in demand for home-based treatments. With hospitals experiencing resource strain due to the pandemic, many patients opted for home care to continue essential medical services. Key market drivers include technological advancements in infusion devices and a growing preference for home treatments, as patients seek more convenient options. Home infusion service providers, such as Option Care Health Inc., are partnering with hospitals and pharmacies to streamline patient access to care and tailor personalized treatment plans. This collaboration has fueled the demand for home infusion supplies and services, especially in developed markets, enhancing the overall landscape of home healthcare solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Home Infusion Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Home Infusion Therapy Market Segmental Analysis

Global Home Infusion Therapy Market is segmented by Product, Application, Administration and Region. Based on Product, the market is segmented into Infusion Pumps (Elastomeric, Electromechanical, Gravity, Others), Intravenous Sets, IV Cannulas, Needleless Connectors. Based on Application, the market is segmented into Anti Infective, Endocrinology (Diabetes, Others), Hydration Therapy (Athletes, Others), Chemotherapy, Enteral Nutrition, Parental Nutrition, Specialty Pharmaceuticals, Others. Based on Administration, the market is segmented into Intramuscular, Subcutaneously, Epidural. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Home Infusion Therapy Market

One of the primary factors fueling the growth of the global home infusion therapy market is the escalating incidence of chronic illnesses, including diabetes, cancer, and cardiovascular diseases. As more individuals require ongoing medical attention and treatment, home infusion therapy emerges as a convenient and effective solution. This method not only minimizes the need for hospital visits but also enhances patient comfort, making it an appealing option for both healthcare providers and patients. The demand for effective management of chronic conditions is expected to further boost the market, highlighting the importance of home infusion services in contemporary healthcare practices.

Restraints in the Global Home Infusion Therapy Market

One significant constraint hindering the expansion of the global home infusion therapy market is the insufficient awareness and training among both healthcare professionals and patients. Many patients lack a clear understanding of home infusion therapy, leading to underutilization of these services. On the other hand, healthcare providers often do not receive adequate training in managing infusion therapies or guiding patients through pre-treatment processes. This knowledge gap not only affects the quality of care provided but also limits patient acceptance and adoption of home infusion therapy, ultimately impacting the overall growth prospects and market share of this vital healthcare sector.

Market Trends of the Global Home Infusion Therapy Market

The global home infusion therapy market is witnessing a significant shift towards patient-centric care, reflecting a growing preference for personalized treatment plans that prioritize individual patient needs. This trend is driven by the increasing demand for convenience and comfort, allowing patients to manage chronic conditions from the comfort of their homes while reducing hospital visits and associated healthcare costs. advancements in infusion technologies, enhanced caregiver training, and improved patient education are further fueling this trend, making home infusion a viable alternative to traditional hospital-based care. As a result, the market is poised for robust growth, catering to a more empowered and involved patient population.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Patent Analysis

Home Infusion Therapy Market Size by Product & CAGR (2024-2031)

• Market Overview
• Infusion Pumps
  • Elastomeric
  • Electromechanical
  • Gravity
  • Others
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

Home Infusion Therapy Market Size by Application & CAGR (2024-2031)

• Market Overview
• Anti Infective
• Endocrinology
  • Diabetes
  • Others
• Hydration Therapy
  • Athletes
  • Others
• Chemotherapy
• Enteral Nutrition
• Parental Nutrition
• Specialty Pharmaceuticals
• Others

Home Infusion Therapy Market Size by Administration & CAGR (2024-2031)

• Market Overview
• Intramuscular
• Subcutaneously
• Epidural

Home Infusion Therapy Market Size & CAGR (2024-2031)

• North America (Product, Application, Administration)
  • US
  • Canada
• Europe (Product, Application, Administration)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Product, Application, Administration)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Product, Application, Administration)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, Administration)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Option Care Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AmerisourceBergen Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CVS Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Walgreens Boots Alliance (USA/UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Linde plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Centene Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UnitedHealth Group (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anthem, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Humana Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cigna Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Conclusion & Recommendation